title: Proposed pharmaceutical regulations for skeletal muscle depolarization drugs.
authors.forename: Brian D
authors.initials: BD
authors.lastname: Andresen
authors.forename: Patrick M
authors.initials: PM
authors.lastname: Grant
authors.forename: John
authors.initials: J
authors.lastname: McKillop
mesh_terms: D004345:Drug Industry / Q000331:legislation & jurisprudence*; D004349:Drug Packaging; D044707:Forensic Sciences / Q000379:methods; D006708:Homicide; D006761:Hospitals; D006801:Humans; D007554:Isotopes; D009467:Neuromuscular Depolarizing Agents / Q000032:analysis / Q000737:chemistry* / Q000506:poisoning; D003473:Neuromuscular Nondepolarizing Agents / Q000032:analysis / Q000737:chemistry* / Q000506:poisoning; D010197:Pancuronium / Q000032:analysis / Q000737:chemistry* / Q000506:poisoning; D013390:Succinylcholine / Q000032:analysis / Q000737:chemistry* / Q000506:poisoning
chemical_list: D007554:Isotopes; D009467:Neuromuscular Depolarizing Agents; D003473:Neuromuscular Nondepolarizing Agents; D013390:Succinylcholine; D010197:Pancuronium